TLSA · Tiziana Life Sciences Ltd · Metrics
Market Cap
$127.26M
Shares
127.26M
Volume · Oct 21
421.48K
Avg daily vol (3M)
761.6K
TLSA metrics
47 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$1.01
Market cap
$127.26M
Price action
20 metricsPrice change (1W)
-7.3%
Price change (30D)
+11.7%
Price change (3M)
+1.0%
Price change (6M)
-17.9%
Price change (YTD)
-32.2%
Price change (1Y)
-48.5%
Trailing year
Price change (5Y)
-39.2%
52-week high
$1.96
52-week low
$0.77
Change from 52-week high
-48.5%
Change from 52-week low
+31.2%
Annualized volatility
80.8%
Annualized volatility (3M)
96.3%
Beta
1.4
RSI (14D)
46.3
Price vs SMA 50
-2.0%
Price vs SMA 200
-18.2%
Avg volume (3M)
760,361
Relative volume
0.4
Average dollar volume
$786,575
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
127.26M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2,471.8
reciprocal yield 0.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+8.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-35,444.2%
Return on assets
-160.3%
Debt / equity
—
Current ratio
0.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$4.01M
Total assets
$11.49M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
31
13F filer change QoQ
-2
Institutional ownership
1.9%
Conviction holders (share of 13F filers)
3.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-26.4%
Holder tenure
6.9
Price vs estimated holder cost
+1.4%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
2.1%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
62 / 100
Insider activity
2 metricsNet insider buying (90D)
$985,909
Insider-sentiment score
89 / 100
Risk flags
1 metricsGoing concern
—